Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rocio Morales-Barcenas"'
Autor:
Alejandro Schcolnik-Cabrera, José Chávez-Díaz, Lucia Taja-Chayeb, Guadalupe Domínguez-Gómez, Alma Chavez-Blanco, Rocio Morales-Barcenas, Marisol Ramírez-Yautentzi, Alfonso Dueáas-González
Publikováno v:
Oncology Letters.
Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of de novo fatty acid synthesis, respectively. Although their antitumor effects have been explored in detail, the potential inhibiti
Autor:
Alejandra Chávez-Riveros, Rocio Morales-Barcenas, Luis D. Miranda, Alfonso Dueñas-González, Alma Chavez-Blanco, Eduardo Hernández-Vázquez, María Teresa Ramírez-Apan, Adriana Romo-Pérez
Publikováno v:
ChemMedChem. 13:1193-1209
Cancer continues to be a worldwide health problem. Certain macrocyclic molecules have become attractive therapeutic alternatives for this disease because of their efficacy and, frequently, their novel mechanisms of action. Herein, we report the synth
Autor:
Rocio Morales-Barcenas, Alma Chavez-Blanco, Lucia Taja-Chayeb, Enrique Pérez-Cárdenas, Guadalupe Domínguez-Gómez, Aurora Gonzalez-Fierro, Alfonso Dueñas-González, Alejandro Schcolnik-Cabrera, Catalina Trejo-Becerril
Publikováno v:
Expert Opinion on Investigational Drugs. 27:475-489
Cancer cells have increased glycolysis and glutaminolysis. Their third feature is increased de novo lipogenesis. As such, fatty acid (FA) synthesis enzymes are over-expressed in cancer and their depletion causes antitumor effects. As fatty acid synth